Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000568:Amenorrhea / Q000097:blood* / Q000188:drug therapy; D000588:Amines / Q000097:blood; D000704:Analysis of Variance; D001921:Brain / Q000201:enzymology; D002395:Catecholamines / Q000502:physiology; D002986:Clinical Trials as Topic; D003863:Depression / Q000209:etiology; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000494:pharmacology; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008593:Menopause; D008598:Menstruation; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000097:blood*; D014050:Toluene / Q000097:blood; D014191:Tranylcypromine / Q000097:blood; D014439:Tyramine / Q000378:metabolism
D000588:Amines; D002395:Catecholamines; D004966:Estrogens, Conjugated (USP); D012739:Gonadal Steroid Hormones; D014191:Tranylcypromine; D014050:Toluene; D008995:Monoamine Oxidase; D008525:Medroxyprogesterone; D014439:Tyramine